Payment Policy Update: Beginning September 1, 2026, Virginia Cancer Specialists will no longer accept cash. Read more here..
A plasma-derived fibrin biomatrix preparation consisting of two separate solutions that are combined on application. The sealer protein solution contains clottable human fibrinogen and bovine aprotinin, a fibrinolysis inhibitor; the thrombin solution contains human thrombin and calcium chloride. When the solutions are combined, a clot is formed, reproducing the final stages of the coagulation cascade. Check for active clinical trials using this agent. (NCI Thesaurus)
Related Posts
Recent Posts
